ARTICLE | Clinical News
Epitope regulatory update
May 23, 1994 7:00 AM UTC
EPT received a letter from the FDA stating that the Beaverton, Ore., company has resolved 40 of the 57 issues raised in the agency's pre-approval inspection report. The remaining issues are primarily ...